Literature DB >> 32379596

Schiff Bases and Complexes: A Review on Anti-Cancer Activity.

Garima Matela1.   

Abstract

Development in the field of bio-inorganic chemistry increased the interest in Schiff base and its complexes due to its biological importance in many fields, including anticancer activity. Discovery of the antitumor activity of Schiff base and its complexes against various tumor cell lines fascinates the researchers to develop new anticancer drugs without any side effects. Thus, the present review focuses on the anticancer activity of Schiff bases and their metal complexes. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  ICMR; Metal (II) complexes; Schiff Base; antitumor activity; bio-inorganic chemistry; tumor cell lines

Mesh:

Substances:

Year:  2020        PMID: 32379596     DOI: 10.2174/1871520620666200507091207

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  3 in total

1.  Solution Equilibrium Studies on Salicylidene Aminoguanidine Schiff Base Metal Complexes: Impact of the Hybridization with L-Proline on Stability, Redox Activity and Cytotoxicity.

Authors:  Orsolya Dömötör; Nóra V May; G Tamás Gál; Gabriella Spengler; Aliona Dobrova; Vladimir B Arion; Éva A Enyedy
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

2.  Antimicrobial activity of silver sulfide quantum dots functionalized with highly conjugated Schiff bases in a one-step synthesis.

Authors:  Nurulizzatul Ningsheh M Shahri; Hussein Taha; Malai Haniti S A Hamid; Eny Kusrini; Jun-Wei Lim; Jonathan Hobley; Anwar Usman
Journal:  RSC Adv       Date:  2022-01-24       Impact factor: 3.361

3.  2-Mercaptobenzimidazole clubbed hydrazone for Alzheimer's therapy: In vitro, kinetic, in silico, and in vivo potentials.

Authors:  Farida Begum; Najeeb Ur Rehman; Ajmal Khan; Sajid Iqbal; Rehan Zafar Paracha; Jalal Uddin; Ahmed Al-Harrasi; Muhammad Arif Lodhi
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.